Beta cell functionality and hepatic insulin resistance are major contributors to type 2 diabetes remission and starting pharmacological therapy: from CORDIOPREV randomized controlled trial
ISSN
19315244
Date Issued
2021
DOI
10.1016/j.trsl.2021.07.001